RFA-AG-24-007: Roybal Centers for Translational Behavioral Research on Dementia Care, Caregiver Support, and Prevention of Alzheimers Disease and Related Dementias (AD/ADRD) (P30 Clinical Trial Required)
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of National Institutes of Health notices from 2023.
National Institutes of Health offered grants of up to $750,000 to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. Applications closed on June 23, 2023.
From the official notice on Grants.gov, last changed March 3, 2023. Checked November 7, 2026.
- Award ceiling$750,000
- Cost sharingNot required
- Funding typeGrant
About this NIH notice
- Activity codeP30
- Clinical trialsRequired
- Funded byNIA
- Median yearly award$833,460
- Typical project length5 years
- P30, Center Core Grant. Shared facilities and services for investigators who already hold research funding on a common theme. Other open P30 notices.
Projects funded under RFA-AG-24-007 were run by National Institute on Aging (NIA, 8 projects). Contact the program officer at the institute that fits your project before you apply; the notice lists them.
Application due dates, page limits and budget limits are set in the notice. Read RFA-AG-24-007 in the NIH Guide.
Key dates
| Posted | March 3, 2023 |
|---|---|
| Deadline | June 23, 2023 |
| Archived by Grants.gov | July 29, 2023 |
Who can apply
This opportunity was open to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses.
All 15 applicant types the notice lists
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
- Small businesses
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Is this a realistic fit?
- Projects NIH funded under this notice had a median yearly award of $833,460; it allows up to $750,000 per award.
- Most of the program's money (73% over five years) went to colleges and universities.
- No cost sharing or match is required.
What the grant funds
This Funding Opportunity Announcement (FOA) solicits Edward R. Roybal Centers for translational intervention development research for Alzheimers Disease and Alzheimers Disease related dementias care provider support. The purpose of the Roybal Centers is to develop behavioral interventions that improve the health, well-being and/or capacity of individuals and/or systems that provide care to persons with AD-ADRD. Roybal Centers will conduct Stage 0 through IV pilot studies in accordance with the multidirectional, translational NIH Stage Model, to produce potent and implementable principle-driven behavioral interventions.
Funded under RFA-AG-24-007 so far
NIH funded 8 projects under RFA-AG-24-007 in fiscal 2024 to 2026, at 8 institutions. The median yearly award was $833,460.
| Project | Institution | Fiscal year | Award |
|---|---|---|---|
| Behavioral Intervention Development Core | Emory University | 2026 | $782,500 |
| Admin-Core | Feinstein Institute for Medical Research | 2026 | $202,439 |
| Closed-loop digital interventions through a remote clinical trials platform. | University of California, San Francisco | 2026 | $1.2 million |
| Establishing Mechanisms of Benefit to Reinforce the Alzheimer's Care Experience AD/ADRD Roybal Center: EMBRACE | University of Minnesota | 2026 | $342,983 |
| Roybal Center for Promoting Adherence to Behavior Change and Enhancing Cognitive Function | University of Michigan at Ann Arbor | 2026 | $950,799 |
| BID Core | University of Illinois at Chicago | 2026 | $872,994 |
| ASU Roybal Administrative Core | Arizona State University-Tempe Campus | 2026 | $380,873 |
| MassaChusetts General Hospital ROybal CeNter For BehavIoral Dyadic ResEarch in Alzheimer's Disease and Related Dementias (CONFIDE-ADRD): Behavioral Intervention Development Core | Massachusetts General Hospital | 2025 | $969,659 |
Who has won Aging Research grants before
From fiscal 2021 to 2025, Aging Research (93.866) awarded $19 billion across 11,026 grant awards, an average of $1.7 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| The Regents of the University of California, San Francisco | California | 337 | $575 million |
| The Trustees of Columbia University in the City of New York | New York | 242 | $574 million |
| University of Southern California | California | 203 | $572 million |
| The Washington University | Missouri | 210 | $556 million |
| Regents of the University of Michigan | Michigan | 232 | $538 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is RFA-AG-24-007 still open?
No. It closed on June 23, 2023.
Who can apply for Roybal Centers for Translational Behavioral Research on Dementia Care, Caregiver Support, and Prevention of Alzheimers Disease and Related Dementias (AD/ADRD) (P30 Clinical Trial Required)?
National Institutes of Health accepted applications from nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. The notice adds further conditions, so read its eligibility section.
What is the deadline for Roybal Centers for Translational Behavioral Research on Dementia Care, Caregiver Support, and Prevention of Alzheimers Disease and Related Dementias (AD/ADRD) (P30 Clinical Trial Required)?
Closed June 23, 2023. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $750,000 each.
Who has been funded under RFA-AG-24-007?
NIH RePORTER lists 8 projects funded under RFA-AG-24-007 in fiscal 2024 to 2026, at 8 institutions. The most were at Emory University, Feinstein Institute for Medical Research, University of California, San Francisco.
Who has won Aging Research grants before?
The largest recipients over five fiscal years were The Regents of the University of California, San Francisco, The Trustees of Columbia University in the City of New York, University of Southern California. The program made 11,026 awards worth $19 billion in that time.
Similar open grants
- Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)
- Diabetes Research Centers (P30 Clinical Trial Optional)
- KUH P30 Resource Core Center (P30 Clinical Trial Not Allowed)
- Silvio O. Conte Digestive Diseases Research Core Centers (P30-Clinical Trial Optional)
- Environmental Health Sciences Core Centers Program (P30 Clinical Trials Optional)
- AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)